These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21899471)

  • 21. Editorial comment--More than one way to lyse a clot.
    Kasner SE
    Stroke; 2004 Apr; 35(4):911-2. PubMed ID: 15044811
    [No Abstract]   [Full Text] [Related]  

  • 22. Thrombolysis in an ischemic stroke patient on dabigatran anticoagulation: a case report.
    Marrone LC; Marrone AC
    Cerebrovasc Dis; 2012; 34(3):246-7. PubMed ID: 23018342
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful treatment of pediatric stroke with recombinant tissue plasminogen activator (rt-PA): a case report and review of the literature.
    Cremer S; Berliner Y; Warren D; Jones AE
    CJEM; 2008 Nov; 10(6):575-8. PubMed ID: 19000355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EMS mythology. EMS myth #2. Thombolytic therapy is the standard of care for acute ischemic stroke.
    Bledsoe BE
    Emerg Med Serv; 2003 Apr; 32(4):63-5. PubMed ID: 12705219
    [No Abstract]   [Full Text] [Related]  

  • 25. Adherence to guidelines by emergency medical services during transport of stroke patients receiving intravenous thrombolytic infusion.
    Asaithambi G; Chaudhry SA; Hassan AE; Rodriguez GJ; Suri MF; Qureshi AI
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e42-5. PubMed ID: 22572162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.
    Demaerschalk BM; Kleindorfer DO; Adeoye OM; Demchuk AM; Fugate JE; Grotta JC; Khalessi AA; Levy EI; Palesch YY; Prabhakaran S; Saposnik G; Saver JL; Smith EE;
    Stroke; 2016 Feb; 47(2):581-641. PubMed ID: 26696642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age and Stroke Severity: Hazards for Intravenous Thrombolysis?
    Long C; Li M
    Med Princ Pract; 2016; 25(1):99-100. PubMed ID: 26457894
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombolytic therapy for acute ischemic stroke: risks vs benefits.
    Lindbloom EJ
    J Fam Pract; 2003 Oct; 52(10):757, 761. PubMed ID: 14529595
    [No Abstract]   [Full Text] [Related]  

  • 29. Intravenous thrombolysis for stroke in patients taking non-VKA oral anticoagulants: an update.
    Cappellari M; Bovi P
    Thromb Haemost; 2015 Aug; 114(2):440-4. PubMed ID: 25809649
    [No Abstract]   [Full Text] [Related]  

  • 30. [The treatment of acute ischemic stroke].
    Csiba L
    Orv Hetil; 2004 Nov; 145(45):2297-301. PubMed ID: 15573895
    [No Abstract]   [Full Text] [Related]  

  • 31. The prospects and predicaments of intravenous rt-PA in childhood ischemic stroke.
    Behrouz R
    Expert Rev Neurother; 2014 Mar; 14(3):255-9. PubMed ID: 24491039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombolytic therapy for patients with acute stroke in the ED setting.
    Blank FS; Keyes M
    J Emerg Nurs; 2000 Feb; 26(1):24-30. PubMed ID: 10657792
    [No Abstract]   [Full Text] [Related]  

  • 33. Update on intravenous recombinant tissue plasminogen activator for acute ischemic stroke.
    Fugate JE; Rabinstein AA
    Mayo Clin Proc; 2014 Jul; 89(7):960-72. PubMed ID: 24775222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Can the target group for thrombolysis in acute ischemic stroke be widened? Current indication is very narrow--new study results are necessary].
    Murray V
    Lakartidningen; 2011 Jan 12-18; 108(1-2):16-7. PubMed ID: 21365808
    [No Abstract]   [Full Text] [Related]  

  • 35. [Thrombolytic therapy in stroke approved with reservation. Underlying evidence, practical guidelines and safety follow up].
    Wahlgren NG
    Lakartidningen; 2004 Feb; 101(8):674-7. PubMed ID: 15024940
    [No Abstract]   [Full Text] [Related]  

  • 36. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous Thrombolysis in Acute Ischemic Stroke Patients Pretreated With Non-Vitamin K Antagonist Oral Anticoagulants: An Editorial Review.
    Tsivgoulis G; Safouris A
    Stroke; 2017 Jul; 48(7):2031-2033. PubMed ID: 28536167
    [No Abstract]   [Full Text] [Related]  

  • 38. The impact of demographic and logistic factors on effectiveness and safety of IV thrombolysis in patients with acute ischemic stroke in a rural hospital in southeastern Poland.
    Sobolewski P; Szczuchniak W; Hatalska-Żerebiec R; Sobota A; Śledzińska-Dźwigał M
    Int J Stroke; 2013 Aug; 8(6):E41. PubMed ID: 23879765
    [No Abstract]   [Full Text] [Related]  

  • 39. Transition of European Cooperative Acute Stroke Study III results to clinical practice: ninety-day outcomes in a US cohort.
    Cronin CA; Langenberg P; Dutta TM; Kittner SJ
    Stroke; 2013 Dec; 44(12):3544-6. PubMed ID: 24092551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombolysis in pediatric stroke study.
    Rivkin MJ; deVeber G; Ichord RN; Kirton A; Chan AK; Hovinga CA; Gill JC; Szabo A; Hill MD; Scholz K; Amlie-Lefond C
    Stroke; 2015 Mar; 46(3):880-5. PubMed ID: 25613306
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.